Multiple sclerosis is a chronic, inflammatory, and neurodegenerative disease of the central
nervous system and a major cause of neurological disability in young adults. Its prevalence …

An increase of multiple sclerosis (MS) incidence has been reported during the last decade,
and this may be connected to environmental factors. This review article aims to encapsulate …

Randomized controlled clinical trials and real-world observational studies provide
complementary information but with different validity. Some clinical questions (disease …

Sleep disturbances and poor sleep are a common complaint in the population with multiple
sclerosis (MS) disease. The most commonly reported scale is the Pittsburgh Sleep Quality …

Objective: To verify the hypothesis of an age-dependent increase of infections and
neoplasms in patients with multiple sclerosis (MS) under disease-modifying treatments …

In recent years, neurological and neurodegenerative disorders research has focused on
altered molecular mechanisms in search of potential pharmacological targets, eg …

Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …

Background The optimal treatment strategy with disease-modifying therapies (DMTs) in
relapsing–remitting multiple sclerosis (RRMS) remains uncertain. Objective To compare …

Introduction: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous
system. The latest development of B-cell depletion by anti-CD20 monoclonal antibodies has …

Objectives Finland is a high‐risk multiple sclerosis (MS) region, but a national MS register
has not existed until 2014. In this paper, we present the Finnish MS register variables and …